SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric ETV6-RUNX1 B-Acute Lymphoblastic Leukemia Patients

Valentina Serafin, Benedetta Accordi|International Journal of Molecular Sciences|2019

Cited by 10